For healthcare professionals

A direct path to epilepsy education and collaboration.

Connect with regional epilepsy expertise through one flagship meeting and one focused case-discussion series. Both are designed for practical learning, direct access and stronger clinician-to-clinician relationships.

Two ways to participate

Start with the program that fits your needs.

Registration takes only a few minutes and immediately provides a calendar invitation.

01Flagship clinician program
OCT 222026

Hudson Valley Epilepsy Exchange

A practical evening for community neurologists, pediatricians, primary care clinicians and advanced practice providers focused on what should happen when seizures continue after appropriate treatment.

6:00–8:00 PMIn-person didactic and hands-on program
View program & register →
02Virtual epilepsy case roundtable
DEC 032026

Bring Your Toughest Case

A focused virtual discussion where community clinicians can join the conversation, propose a difficult case for review or simply learn from the cases selected for the session.

5:00–6:00 PMSmall-group virtual roundtable
View program & register →
Observe multidisciplinary care

Request access to a regional Level 4 epilepsy conference.

Community neurologists and advanced practice providers may request an invitation to observe how a multidisciplinary epilepsy team reviews complex cases and develops treatment recommendations.

FormatLive multidisciplinary conference
ScheduleUpcoming observer dates shared with approved participants
How to request accessSelect the conference-interest option when registering for the case roundtable
Request conference access →
Clinical recognition

When should the pathway change?

Failure of two tolerated, appropriately chosen and used antiseizure medication schedules to achieve sustained seizure freedom meets the ILAE consensus definition of drug-resistant epilepsy.

Review the ILAE resource ↗
01Two appropriate medication trials without sustained seizure freedom
02Persistent disabling events or medication-related burden
03Uncertain diagnosis, discordant data or changing seizure pattern
04Developmental, cognitive, safety or quality-of-life impact